Co-regulated gene expression by oestrogen receptor α and liver receptor homolog-1 is a feature of the oestrogen response in breast cancer cells

Nucleic Acids Research

Volumn 41, Issue 22, 2013, Pages 10228-10240

  Lai, Chun Fui ^a   Flach, Koen D ^b   Alexi, Xanthippi ^b   Fox, Stephen P ^a   Ottaviani, Silvia ^a   Thiruchelvam, Paul T R ^a   Kyle, Fiona J ^a   Thomas, Ross S ^a   Launchbury, Rosalind ^c   Hua, Hui ^a,d   Callaghan, Holly B ^a   Carroll, Jason S ^c   Charles Coombes, R ^a   Zwart, Wilbert ^b   Buluwela, Laki ^a   Ali, Simak ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

^c IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^d SICHUAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR ALPHA; LIVER RECEPTOR HOMOLOG 1; PROTEIN PS2;

ARTICLE; BINDING SITE; BREAST CANCER; CANCER CELL; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; ESTROGEN RESPONSIVE ELEMENT; GENE; GENE CONTROL; GENE EXPRESSION REGULATION; GENE ONTOLOGY; GENE TARGETING; MICROARRAY ANALYSIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PS2 GENE; RNA INTERFERENCE;

ANIMALS; BREAST NEOPLASMS; CERCOPITHECUS AETHIOPS; COS CELLS; ESTROGEN RECEPTOR ALPHA; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; MCF-7 CELLS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RESPONSE ELEMENTS;

EID: 84890379394     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkt827     Document Type: Article

References (81)

1. Hewitt, S.C., Harrell, J.C. and Korach, K.S. (2005) Lessons in estrogen biology from knockout and transgenic animals. Annu. Rev. Physiol., 67, 285-308.
2. Deroo, B.J. and Korach, K.S. (2006) Estrogen receptors and human disease. J. Clin. Invest., 116, 561-570.
3. Ali, S., Buluwela, L. and Coombes, R.C. (2011) Antiestrogens and their therapeutic applications in breast cancer and other diseases. Annu. Rev. Med., 62, 217-232.
4. Ali, S. and Coombes, R.C. (2002) Endocrine-responsive breast cancer and strategies for combating resistance. Nat. Rev. Cancer, 2, 101-112.
5. O'Donnell, A.J., Macleod, K.G., Burns, D.J., Smyth, J.F. and Langdon, S.P. (2005) Estrogen receptor-alpha mediates gene expression changes and growth response in ovarian cancer cells exposed to estrogen. Endocr. Relat. Cancer, 12, 851-866.
6. Shang, Y. (2006) Molecular mechanisms of oestrogen and SERMs in endometrial carcinogenesis. Nat. Rev. Cancer, 6, 360-368.
7. Mangelsdorf, D.J., Thummel, C., Beato, M., Herrlich, P., Schutz, G., Umesono, K., Blumberg, B., Kastner, P., Mark, M., Chambon, P. et al. (1995) The nuclear receptor superfamily: the second decade. Cell, 83, 835-839.
8. Dahlman-Wright, K., Cavailles, V., Fuqua, S.A., Jordan, V.C., Katzenellenbogen, J.A., Korach, K.S., Maggi, A., Muramatsu, M., Parker, M.G. and Gustafsson, J.A. (2006) International union of pharmacology. LXIV. Estrogen receptors. Pharmacol. Rev., 58, 773-781.
9. Osborne, C.K. and Schiff, R. (2011) Mechanisms of endocrine resistance in breast cancer. Annu. Rev. Med., 62, 233-247.
10. Bjornstrom, L. and Sjoberg, M. (2005) Mechanisms of estrogen receptor signaling: convergence of genomic and nongenomic actions on target genes. Mol. Endocrinol., 19, 833-842.
11. Safe, S. and Kim, K. (2008) Non-classical genomic estrogen receptor (ER)/specificity protein and ER/activating protein-1 signaling pathways. J. Mol. Endocrinol., 41, 263-275.
12. Shang, Y., Hu, X., DiRenzo, J., Lazar, M.A. and Brown, M. (2000) Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription. Cell, 103, 843-852.
13. Metivier, R., Penot, G., Hubner, M.R., Reid, G., Brand, H., Kos, M. and Gannon, F. (2003) Estrogen receptor-alpha directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter. Cell, 115, 751-763.
14. Reid, G., Hubner, M.R., Metivier, R., Brand, H., Denger, S., Manu, D., Beaudouin, J., Ellenberg, J. and Gannon, F. (2003) Cyclic, proteasome-mediated turnover of unliganded and liganded ERalpha on responsive promoters is an integral feature of estrogen signaling. Mol. Cell, 11, 695-707.
15. Metivier, R., Reid, G. and Gannon, F. (2006) Transcription in four dimensions: nuclear receptor-directed initiation of gene expression. EMBO Rep., 7, 161-167.
16. Carroll, J.S., Liu, X.S., Brodsky, A.S., Li, W., Meyer, C.A., Szary, A.J., Eeckhoute, J., Shao, W., Hestermann, E.V., Geistlinger, T.R. et al. (2005) Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1. Cell, 122, 33-43.
17. Lin, C.Y., Vega, V.B., Thomsen, J.S., Zhang, T., Kong, S.L., Xie, M., Chiu, K.P., Lipovich, L., Barnett, D.H., Stossi, F. et al. (2007) Whole-genome cartography of estrogen receptor alpha binding sites. PLoS Genet., 3, e87.
18. Fullwood, M.J., Liu, M.H., Pan, Y.F., Liu, J., Xu, H., Mohamed, Y.B., Orlov, Y.L., Velkov, S., Ho, A., Mei, P.H. et al. (2009) An oestrogen-receptor- alpha-bound human chromatin interactome. Nature, 462, 58-64.
19. Welboren, W.J., van Driel, M.A., Janssen-Megens, E.M., van Heeringen, S.J., Sweep, F.C., Span, P.N. and Stunnenberg, H.G. (2009) ChIP-Seq of ERalpha and RNA polymerase II defines genes differentially responding to ligands. EMBO J., 28, 1418-1428.
20. Ross-Innes, C.S., Stark, R., Teschendorff, A.E., Holmes, K.A., Ali, H.R., Dunning, M.J., Brown, G.D., Gojis, O., Ellis, I.O., Green, A.R. et al. (2012) Differential oestrogen receptor binding is associated with clinical outcome in breast cancer. Nature, 481, 389-393.
21. Lacroix, M. and Leclercq, G. (2004) About GATA3, HNF3A, and XBP1, three genes co-expressed with the oestrogen receptor-alpha gene (ESR1) in breast cancer. Mol. Cell. Endocrinol., 219, 1-7.
22. Cirillo, L.A., Lin, F.R., Cuesta, I., Friedman, D., Jarnik, M. and Zaret, K.S. (2002) Opening of compacted chromatin by early developmental transcription factors HNF3 (FoxA) and GATA-4. Mol. Cell, 9, 279-289.
23. Laganiere, J., Deblois, G., Lefebvre, C., Bataille, A.R., Robert, F. and Giguere, V. (2005) Location analysis of estrogen receptor alpha target promoters reveals that FOXA1 defines a domain of the estrogen response. Proc. Natl Acad. Sci. USA, 102, 11651-11656.
24. Hurtado, A., Holmes, K.A., Ross-Innes, C.S., Schmidt, D. and Carroll, J.S. (2011) FOXA1 is a key determinant of estrogen receptor function and endocrine response. Nat. Genet., 43, 27-33.
25. Theodorou, V., Stark, R., Menon, S. and Carroll, J.S. (2013) GATA3 acts upstream of FOXA1 in mediating ESR1 binding by shaping enhancer accessibility. Genome Res., 23, 12-22.
26. Tan, S.K., Lin, Z.H., Chang, C.W., Varang, V., Chng, K.R., Pan, Y.F., Yong, E.L., Sung, W.K. and Cheung, E. (2011) AP-2gamma regulates oestrogen receptor-mediated long-range chromatin interaction and gene transcription. EMBO J., 30, 2569-2581.
27. Magnani, L., Eeckhoute, J. and Lupien, M. (2011) Pioneer factors: directing transcriptional regulators within the chromatin environment. Trends Genet., 27, 465-474.
28. Roman, S.D., Ormandy, C.J., Manning, D.L., Blamey, R.W., Nicholson, R.I., Sutherland, R.L. and Clarke, C.L. (1993) Estradiol induction of retinoic acid receptors in human breast cancer cells. Cancer Res., 53, 5940-5945.
29. Rishi, A.K., Shao, Z.M., Baumann, R.G., Li, X.S., Sheikh, M.S., Kimura, S., Bashirelahi, N. and Fontana, J.A. (1995) Estradiol regulation of the human retinoic acid receptor alpha gene in human breast carcinoma cells is mediated via an imperfect half-palindromic estrogen response element and Sp1 motifs. Cancer Res., 55, 4999-5006.
30. Hua, S., Kittler, R. and White, K.P. (2009) Genomic antagonism between retinoic acid and estrogen signaling in breast cancer. Cell, 137, 1259-1271.
31. Ross-Innes, C.S., Stark, R., Holmes, K.A., Schmidt, D., Spyrou, C., Russell, R., Massie, C.E., Vowler, S.L., Eldridge, M. and Carroll, J.S. (2010) Cooperative interaction between retinoic acid receptoralpha and estrogen receptor in breast cancer. Genes Dev., 24, 171-182.
32. Peters, A.A., Buchanan, G., Ricciardelli, C., Bianco-Miotto, T., Centenera, M.M., Harris, J.M., Jindal, S., Segara, D., Jia, L., Moore, N.L. et al. (2009) Androgen receptor inhibits estrogen receptor-alpha activity and is prognostic in breast cancer. Cancer Res., 69, 6131-6140.
33. Farmer, P., Bonnefoi, H., Becette, V., Tubiana-Hulin, M., Fumoleau, P., Larsimont, D., Macgrogan, G., Bergh, J., Cameron, D., Goldstein, D. et al. (2005) Identification of molecular apocrine breast tumours by microarray analysis. Oncogene, 24, 4660-4671.
34. Doane, A.S., Danso, M., Lal, P., Donaton, M., Zhang, L., Hudis, C. and Gerald, W.L. (2006) An estrogen receptor-negative breast cancer subset characterized by a hormonally regulated transcriptional program and response to androgen. Oncogene, 25, 3994-4008.
35. Robinson, J.L., Macarthur, S., Ross-Innes, C.S., Tilley, W.D., Neal, D.E., Mills, I.G. and Carroll, J.S. (2011) Androgen receptor driven transcription in molecular apocrine breast cancer is mediated by FoxA1. EMBO J., 30, 3019-3027.
36. Fayard, E., Auwerx, J. and Schoonjans, K. (2004) LRH-1: an orphan nuclear receptor involved in development, metabolism and steroidogenesis. Trends Cell Biol., 14, 250-260.
37. Fernandez-Marcos, P.J., Auwerx, J. and Schoonjans, K. (2011) Emerging actions of the nuclear receptor LRH-1 in the gut. Biochim. Biophys. Acta, 1812, 947-955.
38. Venteclef, N., Jakobsson, T., Ehrlund, A., Damdimopoulos, A., Mikkonen, L., Ellis, E., Nilsson, L.M., Parini, P., Janne, O.A., Gustafsson, J.A. et al. (2010) GPS2-dependent corepressor/SUMO pathways govern anti-inflammatory actions of LRH-1 and LXRbeta in the hepatic acute phase response. Genes Dev., 24, 381-395.
39. Duggavathi, R., Volle, D.H., Mataki, C., Antal, M.C., Messaddeq, N., Auwerx, J., Murphy, B.D. and Schoonjans, K. (2008) Liver receptor homolog 1 is essential for ovulation. Genes Dev., 22, 1871-1876.
40. Clyne, C.D., Kovacic, A., Speed, C.J., Zhou, J., Pezzi, V. and Simpson, E.R. (2004) Regulation of aromatase expression by the nuclear receptor LRH-1 in adipose tissue. Mol. Cell. Endocrinol., 215, 39-44.
41. Clyne, C.D., Speed, C.J., Zhou, J. and Simpson, E.R. (2002) Liver receptor homologue-1 (LRH-1) regulates expression of aromatase in preadipocytes. J. Biol. Chem., 277, 20591-20597.
42. Pare, J.F., Malenfant, D., Courtemanche, C., Jacob-Wagner, M., Roy, S., Allard, D. and Belanger, L. (2004) The fetoprotein transcription factor (FTF) gene is essential to embryogenesis and cholesterol homeostasis and is regulated by a DR4 element. J. Biol. Chem., 279, 21206-21216.
43. Gu, P., Goodwin, B., Chung, A.C., Xu, X., Wheeler, D.A., Price, R.R., Galardi, C., Peng, L., Latour, A.M., Koller, B.H. et al. (2005) Orphan nuclear receptor LRH-1 is required to maintain Oct4 expression at the epiblast stage of embryonic development. Mol. Cell. Biol., 25, 3492-3505.
44. Heng, J.C., Feng, B., Han, J., Jiang, J., Kraus, P., Ng, J.H., Orlov, Y.L., Huss, M., Yang, L., Lufkin, T. et al. (2010) The nuclear receptor Nr5a2 can replace Oct4 in the reprogramming of murine somatic cells to pluripotent cells. Cell Stem Cell, 6, 167-174.
45. Wang, W., Yang, J., Liu, H., Lu, D., Chen, X., Zenonos, Z., Campos, L.S., Rad, R., Guo, G., Zhang, S. et al. (2011) Rapid and efficient reprogramming of somatic cells to induced pluripotent stem cells by retinoic acid receptor gamma and liver receptor homolog 1. Proc. Natl Acad. Sci. USA, 108, 18283-18288.
46. Schoonjans, K., Dubuquoy, L., Mebis, J., Fayard, E., Wendling, O., Haby, C., Geboes, K. and Auwerx, J. (2005) Liver receptor homolog 1 contributes to intestinal tumor formation through effects on cell cycle and inflammation. Proc. Natl Acad. Sci. USA, 102, 2058-2062.
47. Benod, C., Vinogradova, M.V., Jouravel, N., Kim, G.E., Fletterick, R.J. and Sablin, E.P. (2011) Nuclear receptor liver receptor homologue 1 (LRH-1) regulates pancreatic cancer cell growth and proliferation. Proc. Natl Acad. Sci. USA, 108, 16927-16931.
48. Petersen, G.M., Amundadottir, L., Fuchs, C.S., Kraft, P., Stolzenberg-Solomon, R.Z., Jacobs, K.B., Arslan, A.A., Bueno-de-Mesquita, H.B., Gallinger, S., Gross, M. et al. (2010) A genomewide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33. Nat. Genet., 42, 224-228.
49. Lazarus, K.A., Wijayakumara, D., Chand, A.L., Simpson, E.R. and Clyne, C.D. (2012) Therapeutic potential of Liver Receptor Homolog-1 modulators. J. Steroid Biochem. Mol. Biol., 130, 138-146.
50. Dunbier, A.K., Anderson, H., Ghazoui, Z., Folkerd, E.J., A'Hern, R., Crowder, R.J., Hoog, J., Smith, I.E., Osin, P., Nerurkar, A. et al. (2010) Relationship between plasma estradiol levels and estrogenresponsive gene expression in estrogen receptor-positive breast cancer in postmenopausal women. J. Clin. Oncol., 28, 1161-1167.
51. Lonning, P.E., Haynes, B.P., Straume, A.H., Dunbier, A., Helle, H., Knappskog, S. and Dowsett, M. (2011) Recent data on intratumor estrogens in breast cancer. Steroids, 76, 786-791.
52. Annicotte, J.S., Chavey, C., Servant, N., Teyssier, J., Bardin, A., Licznar, A., Badia, E., Pujol, P., Vignon, F., Maudelonde, T. et al. (2005) The nuclear receptor liver receptor homolog-1 is an estrogen receptor target gene. Oncogene, 24, 8167-8175.
53. Thiruchelvam, P.T., Lai, C.F., Hua, H., Thomas, R.S., Hurtado, A., Hudson, W., Bayly, A.R., Kyle, F.J., Periyasamy, M., Photiou, A. et al. (2011) The liver receptor homolog-1 regulates estrogen receptor expression in breast cancer cells. Breast Cancer Res. Treat., 127, 385-396.
54. Miki, Y., Clyne, C.D., Suzuki, T., Moriya, T., Shibuya, R., Nakamura, Y., Ishida, T., Yabuki, N., Kitada, K., Hayashi, S. et al. (2006) Immunolocalization of liver receptor homologue-1 (LRH-1) in human breast carcinoma: possible regulator of insitu steroidogenesis. Cancer Lett., 244, 24-33.
55. Chand, A.L., Herridge, K.A., Thompson, E.W. and Clyne, C.D. (2010) The orphan nuclear receptor LRH-1 promotes breast cancer motility and invasion. Endocr. Relat. Cancer, 17, 965-975.
56. Whitby, R.J., Dixon, S., Maloney, P.R., Delerive, P., Goodwin, B.J., Parks, D.J. and Willson, T.M. (2006) Identification of small molecule agonists of the orphan nuclear receptors liver receptor homolog-1 and steroidogenic factor-1. J. Med. Chem., 49, 6652-6655.
57. Wang, W., Zhang, C., Marimuthu, A., Krupka, H.I., Tabrizizad, M., Shelloe, R., Mehra, U., Eng, K., Nguyen, H., Settachatgul, C. et al. (2005) The crystal structures of human steroidogenic factor-1 and liver receptor homologue-1. Proc. Natl Acad. Sci. USA, 102, 7505-7510.
58. Tora, L., Mullick, A., Metzger, D., Ponglikitmongkol, M., Park, I. and Chambon, P. (1989) The cloned human oestrogen receptor contains a mutation which alters its hormone binding properties. EMBO J., 8, 1981-1986.
59. Lu, D., Kiriyama, Y., Lee, K.Y. and Giguere, V. (2001) Transcriptional regulation of the estrogen-inducible pS2 breast cancer marker gene by the ERR family of orphan nuclear receptors. Cancer Res., 61, 6755-6761.
60. Lucey, M.J., Chen, D., Lopez-Garcia, J., Hart, S.M., Phoenix, F., Al-Jehani, R., Alao, J.P., White, R., Kindle, K.B., Losson, R. et al. (2005) T:G mismatch-specific thymine-DNA glycosylase (TDG) as a coregulator of transcription interacts with SRC1 family members through a novel tyrosine repeat motif. Nucleic Acids Res., 33, 6393-6404.
61. Lopez-Garcia, J., Periyasamy, M., Thomas, R.S., Christian, M., Leao, M., Jat, P., Kindle, K.B., Heery, D.M., Parker, M.G., Buluwela, L. et al. (2006) ZNF366 is an estrogen receptor corepressor that acts through CtBP and histone deacetylases. Nucleic Acids Res., 34, 6126-6136.
62. Metzger, D., Berry, M., Ali, S. and Chambon, P. (1995) Effect of antagonists on DNA binding properties of the human estrogen receptor in vitro and in vivo. Mol. Endocrinol., 9, 579-591.
63. Schmidt, D., Wilson, M.D., Spyrou, C., Brown, G.D., Hadfield, J. and Odom, D.T. (2009) ChIP-seq: using high-throughput sequencing to discover protein-DNA interactions. Methods, 48, 240-248.
64. Zhang, Y., Liu, T., Meyer, C.A., Eeckhoute, J., Johnson, D.S., Bernstein, B.E., Nusbaum, C., Myers, R.M., Brown, M., Li, W. et al. (2008) Model-based analysis of ChIP-Seq (MACS). Genome Biol., 9, R137.
65. He, H.H., Meyer, C.A., Shin, H., Bailey, S.T., Wei, G., Wang, Q., Zhang, Y., Xu, K., Ni, M., Lupien, M. et al. (2010) Nucleosome dynamics define transcriptional enhancers. Nat. Genet., 42, 343-347.
66. Ji, X., Li, W., Song, J., Wei, L. and Liu, X.S. (2006) CEAS: cisregulatory element annotation system. Nucleic Acids Res., 34, W551-W554.
67. Ye, T., Krebs, A.R., Choukrallah, M.A., Keime, C., Plewniak, F., Davidson, I. and Tora, L. (2011) seqMINER: an integrated ChIPseq data interpretation platform. Nucleic Acids Res., 39, e35.
68. Huang da, W., Sherman, B.T. and Lempicki, R.A. (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc., 4, 44-57.
69. Solomon, I.H., Hager, J.M., Safi, R., McDonnell, D.P., Redinbo, M.R. and Ortlund, E.A. (2005) Crystal structure of the human LRH-1 DBD-DNA complex reveals Ftz-F1 domain positioning is required for receptor activity. J. Mol. Biol., 354, 1091-1102.
70. Carroll, J.S., Meyer, C.A., Song, J., Li, W., Geistlinger, T.R., Eeckhoute, J., Brodsky, A.S., Keeton, E.K., Fertuck, K.C., Hall, G.F. et al. (2006) Genome-wide analysis of estrogen receptor binding sites. Nat. Genet., 38, 1289-1297.
71. Zwart, W., Theodorou, V., Kok, M., Canisius, S., Linn, S. and Carroll, J.S. (2011) Oestrogen receptor-co-factor-chromatin specificity in the transcriptional regulation of breast cancer. EMBO J., 30, 4764-4776.
72. Ruthenburg, A.J., Allis, C.D. and Wysocka, J. (2007) Methylation of lysine 4 on histone H3: intricacy of writing and reading a single epigenetic mark. Mol. Cell, 25, 15-30.
73. Goodwin, B., Jones, S.A., Price, R.R., Watson, M.A., McKee, D.D., Moore, L.B., Galardi, C., Wilson, J.G., Lewis, M.C., Roth, M.E. et al. (2000) A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis. Mol. Cell, 6, 517-526.
74. Lu, T.T., Makishima, M., Repa, J.J., Schoonjans, K., Kerr, T.A., Auwerx, J. and Mangelsdorf, D.J. (2000) Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors. Mol. Cell, 6, 507-515.
75. Luo, Y., Liang, C.P. and Tall, A.R. (2001) The orphan nuclear receptor LRH-1 potentiates the sterol-mediated induction of the human CETP gene by liver X receptor. J. Biol. Chem., 276, 24767-24773.
76. Watanabe, M., Houten, S.M., Wang, L., Moschetta, A., Mangelsdorf, D.J., Heyman, R.A., Moore, D.D. and Auwerx, J. (2004) Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c. J. Clin. Invest., 113, 1408-1418.
77. Matsukuma, K.E., Wang, L., Bennett, M.K. and Osborne, T.F. (2007) A key role for orphan nuclear receptor liver receptor homologue-1 in activation of fatty acid synthase promoter by liver X receptor. J. Biol. Chem., 282, 20164-20171.
78. Chong, H.K., Biesinger, J., Seo, Y.K., Xie, X. and Osborne, T.F. (2012) Genome-wide analysis of hepatic LRH-1 reveals a promoter binding preference and suggests a role in regulating genes of lipid metabolism in concert with FXR. BMC Genomics, 13, 51.
79. Chong, H.K., Infante, A.M., Seo, Y.K., Jeon, T.I., Zhang, Y., Edwards, P.A., Xie, X. and Osborne, T.F. (2010) Genome-wide interrogation of hepatic FXR reveals an asymmetric IR-1 motif and synergy with LRH-1. Nucleic Acids Res., 38, 6007-6017.
80. Chand, A.L., Wijayakumara, D.D., Knower, K.C., Herridge, K.A., Howard, T.L., Lazarus, K.A. and Clyne, C.D. (2012) The orphan nuclear receptor LRH-1 and ERalpha activate GREB1 expression to induce breast cancer cell proliferation. PLoS One, 7, e31593.
81. Voss, T.C., Schiltz, R.L., Sung, M.H., Yen, P.M., Stamatoyannopoulos, J.A., Biddie, S.C., Johnson, T.A., Miranda, T.B., John, S. and Hager, G.L. (2011) Dynamic exchange at regulatory elements during chromatin remodeling underlies assisted loading mechanism. Cell, 146, 544-554.